IMI2 - Call 21
IMI2 - Call 21 was launched on 3 March 2020 with the following topic:
- Development of therapeutics and diagnostics combatting coronavirus infections
More information on the Call can be found in IMI's press release and the Call text as well as the questions and answers document. Other relevant documents can be found on the IMI2 Call documents page.
Projects
The projects resulting from IMI2 - Call 21 are:
Diagnostics projects
- COVID-RED - COVID-19 infections - remote early detection
factsheet | website | interview with the project coordinators - DECISION - A minituarized disposable molecular diagnostics platform for combatting coronavirus infections
factsheet | interview with the project coordinators - DRAGON - Rapid and secure AI imaging based diagnosis, stratification, follow-up, and preparedness for coronavirus pandemics
factsheet | website | interview with the project coordinators - KRONO - Evaluation of a production ready portable, point-of-need platform (instrument and reagents), direct from nasal swab test for the molecular diagnostic detection of COVID-19 infection
factsheet | interview with the project coordinators - RAPID-COVID - Robust automation and point of care identification of COVID
factsheet | website | interview with the project coordinators
Treatment projects
- CARE - Corona Accelerated R&D in Europe
factsheet | website | interview with the project coordinators - Imprentri - Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS)
factsheet | website | interview with the project coordinators - MAD-CoV 2 - Modern approaches for developing antivirals against SARS-CoV 2
factsheet | website | interview with the project coordinators
Call statistics
- Proposals submitted: 144
- Inadmissible & ineligible proposals: 24
- Proposals recommended for funding: 12
- Proposals not recommended for funding: 108
Note: As there was a budget ceiling for the Call, only the 8 top-ranked projects received funding.